Wird geladen...

A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer

A phase I study was carried out to determine the optimal dose and administration schedule for combined UFT plus gemcitabine therapy in patients with non-small cell lung cancer. Twenty-four patients (including 11 patients previously treated with cisplatin as the key drug) received oral UFT 400 mg m(−...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seto, T, Yoh, K, Asoh, H, Yamamoto, H, Semba, H, Ichinose, Y
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2002
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375416/
https://ncbi.nlm.nih.gov/pubmed/12087453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600337
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!